Observe Medical (OBSRV) Company presentation summary

Business and product

• Nordic medtech portfolio spans urine measurement, anesthesia and ICU, and wound care, sold through Nordic direct operations and a growing European distributor network.

• Sippi is a digital urine meter for ICUs and wards, combining automated measurement, wireless transfer to hospital patient-data systems, and technology designed to detect and hinder bacterial biofilm formation.

• The presentation links manual hourly urine monitoring with inaccurate clinical data, staff time and ergonomic burdens, and infection risks; Sippi is positioned to improve data quality, staff capacity, and infection control.

Market and commercialization

• The estimated opportunity includes ~400,000 ICU beds and 24M annual ICU admissions, with potential for ~0.5M Sippi base units and 30M+ disposable units per year.

• COVID-related trends were expected to increase ICU beds and annual admissions by 10–15%; other cited drivers include staff shortages, remote monitoring, digital data, and infection control.

• Commercialization focus was clinical rollout in the Nordics and selected European markets, followed by a broader EU launch and global expansion.

• Customer access was expected to return gradually in H2 2021, enabling acceleration of rollout; clinical sites had begun evaluations and customers were positive about resuming implementation.

Execution and clinical evidence

• Year-to-date milestones included ~15 Sippi systems delivered to clinical sites, strengthened global patent protection, expanded customer feedback, and new scientific evidence.

• Nordic portfolio execution included MSEK 10 in disposable-product orders to a hospital region and a blood-warmer order for three Nordic hospitals.

• A doctoral dissertation reported higher staff ratings for the automatic urinometer than the manual alternative on user-friendliness, reliability, safety, and efficacy.

• New study applications at Nya Karolinska Sjukhuset were submitted in May 2021 to broaden clinical use, including investigation of urine-flow measurements for diagnostic parameters such as acute kidney injury.